NewCardio, Inc.
NWCI · OTC
12/31/2010 | 12/31/2009 | 12/31/2008 | 12/31/2007 | |
|---|---|---|---|---|
| Revenue | $257 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $152 | $0 | $0 | $0 |
| Gross Profit | $105 | $0 | $0 | $0 |
| % Margin | 40.8% | – | – | – |
| R&D Expenses | $3,585 | $3,048 | $2,126 | $370 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $5,916 | $6,905 | $7,180 | $1,730 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $63 | $0 | $0 | $0 |
| Operating Expenses | $9,564 | $10,012 | $9,324 | $2,100 |
| Operating Income | -$9,459 | -$10,012 | -$9,324 | -$2,100 |
| % Margin | -3,674.8% | – | – | – |
| Other Income/Exp. Net | -$2,037 | $422 | -$4,857 | -$7,200 |
| Pre-Tax Income | -$11,285 | -$9,591 | -$14,182 | -$9,301 |
| Tax Expense | $2,037 | $0 | $0 | $0 |
| Net Income | -$11,496 | -$9,591 | -$14,182 | -$9,301 |
| % Margin | -4,466.2% | – | – | – |
| EPS | -0.4 | -0.44 | -0.68 | -0.85 |
| % Growth | 9.1% | 35.3% | 20% | – |
| EPS Diluted | -0.4 | -0.44 | -0.68 | -0.85 |
| Weighted Avg Shares Out | 28,638 | 23,726 | 20,945 | 10,953 |
| Weighted Avg Shares Out Dil | 28,638 | 23,726 | 20,945 | 10,953 |
| Supplemental Information | – | – | – | – |
| Interest Income | $119 | $0 | $0 | $0 |
| Interest Expense | $331 | $0 | $0 | $7,200 |
| Depreciation & Amortization | $80 | $60 | $19 | $6 |
| EBITDA | -$9,379 | -$9,018 | -$4,293 | -$2,095 |
| % Margin | -3,643.8% | – | – | – |